Gain Therapeutics, Inc.GANXNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-6.33%
↓ 111% below average
Average (6y)
57.79%
Historical baseline
Range
High:225.29%
Low:-6.33%
Volatility
400.8%
High variability
| Period | Value |
|---|---|
| 2024 | -6.33% |
| 2023 | 36.19% |
| 2022 | 15.11% |
| 2021 | 225.29% |
| 2020 | 42.42% |
| 2019 | 91.83% |
| 2018 | 0.00% |